What we doOur groundbreaking software predicts protein complex changes in response to diseases and drug treatments using a wide range of information on cellular processes. Revolutionize your drug discovery pipeline, optimize treatments, and personalize patient care through our innovative software tools.
Our groundbreaking software predicts protein complex changes in response to diseases and drug treatments using a wide range of information on cellular processes. Revolutionize your drug discovery pipeline, optimize treatments, and personalize patient care through our innovative software tools.
What We do
At Cytocast, we created the Clinical Digital Twin (CDT) because we saw a critical problem in drug development that no one else was solving. Despite tens of thousands of screening assays conducted to assess efficacy and toxicity, multi-million-dollar drug projects too often fail late in clinical trials due to subtle, grievous side effects.
We offer cutting-edge technology solutions designed to enhance and support the healthcare industry's capabilities and bring meaningful progress to the field. It benefits a broad range of clients in the healthcare industry, including pharmaceutical companies, biotech firms, medical research organisations, and healthcare providers.
Our focus is evaluating drug efficacy and side effects in silico. Potential further applications of our technology include identifying and characterizing drug targets, finding drug repurposing potentials, optimizing drug development pipelines, identifying potential drug combinations and synergies, predicting patient responses to treatments, personalizing treatment plans for patients.
